Burcke named associate vice chancellor for finance
Brianne Burcke has been named associate vice chancellor for finance and chief of staff to Amy Kweskin, executive vice chancellor of finance, at Washington University in St. Louis.
WashU employees invited to drive-in movie night
WashU employees are invited to take part in a drive-in movie Aug. 4 in Belleville, Ill. Space is limited, so reserve your spot today.
New student representatives named to Board of Trustees
The Washington University Board of Trustees has four new student representatives for the 2022-23 academic year.
Barch named vice dean of research in Arts & Sciences
Deanna Barch, chair and professor of psychological and brain sciences, has been named vice dean of research in Arts & Sciences. Her new role took effect July 1.
A one-two punch for photoacoustic imaging
A team led by Song Hu at the McKelvey School of Engineering found a way to measure biomarkers in the body with higher accuracy by combining a Bessel beam with deep learning.
One-hit wonder: How awards, recognition decrease inventors’ creativity
New research from Olin Business School has identified one reason why some first-time producers struggle to repeat their initial creative productions while others go on to continually produce creative works.
Ley honored for groundbreaking leukemia research
Timothy J. Ley, MD, at the School of Medicine, has been honored by the American Society of Hematology with the Henry Stratton Medal for outstanding contributions to hematology. Ley also recently was honored by France’s Fondation ARC for cancer research.
Wearable ultrasound sensors for human brain in development
The McKelvey School of Engineering’s Hong Chen and her team are developing tiny sensors to detect blast-induced traumatic brain injury with new funding from the Office of Naval Research.
New center’s aim: to ID biomarkers of neurodegenerative diseases
The Tracy Family SILQ Center for Neurodegenerative Biology has been established at the School of Medicine. The center aims to help researchers discover, study and validate biomarkers of neurodegenerative diseases such as Alzheimer’s and Parkinson’s, with a goal of identifying new drug targets and creating better diagnostic and prognostic tests.
Holtzman receives grant to fund lung disease drug development
Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine and director of the Division of Pulmonary and Critical Care Medicine at the School of Medicine, received a $2.5 million grant from the Department of Defense for work toward a novel drug to treat lung disease.
View More Stories